Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: license revenues of the Js WERE accounted for : to Brian

I think I remember reading that TPL, and PTSC announce settlements after a contract has been signed, not necessarily when funds are recieved.

WE must remember that a MOU is not a contract.

Perhaps that is why they announced it as a "Business Resolution"

Share
New Message
Please login to post a reply